Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children [NA]
This completed clinical trial evaluated the impact of rice bran and cooked navy beans on cholesterol levels in healthy children; results wer…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C
Clinical trial update analyzing HDL protein and phospholipid composition in patients with very high HDL-C levels. The study status is TERMIN…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. [Phase 4]
Phase 4 clinical trial evaluating combination cholesterol therapies in patients with high cholesterol; status is completed.
-
FDA approval · 2017-03-27FDA Approved: ATORVASTATIN CALCIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's atorvastatin calcium as an original-application generic product.
-
FDA approval · 2017-03-21FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Ascend Laboratories, LLC)
FDA approves the original ANDA for rosuvastatin calcium from Ascend Laboratories, LLC, enabling the generic rosuvastatin calcium product to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Dietary Effects on Weight Loss and Lipid Profile in Sedentary Men [NA]
The completed trial titled 'Dietary Effects on Weight Loss and Lipid Profile in Sedentary Men' evaluated how a dietary intervention influenc…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Elevated Serum HDL in Four Generations of a Nashville Family
This clinical trial update reports elevated serum HDL across four generations in a Nashville family, studying familial hyperlipidemia. The s…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Improving Heart Health in Appalachia [NA]
This clinical trial update notes the completion of a study aimed at improving heart health in Appalachian populations, focusing on obesity, …
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Controlled Trial of High Dietary Fiber Intake on Serum Lipids [NA]
A completed clinical trial evaluated the effect of high dietary fiber intake on serum lipid levels in individuals with hyperlipidemia.
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Hyperlipidemia Therapy TERCET Zabrze Registry
Clinical trial registry update for a hyperlipidemia therapy (TERCET) at Silesian Centre for Heart Diseases; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care [NA]
Clinical trial update for the TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care trial (NCT01418716) with completed st…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) [Phase 3]
Phase 3 trial update showing completion of a study evaluating an investigational compound's effect on the tolerability of extended-release n…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) [Phase 3]
Phase 3 trial comparing tolerability of MK0524A to niacin extended-release in patients with high cholesterol has completed.
-
FDA approval · 2017-02-03FDA Approved: PITAVASTATIN — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's original application for pitavastatin calcium, a generic statin indicated to treat hyperlipidemia by lowering cholestero…
-
FDA approval · 2017-02-03FDA Approved: PITAVASTATIN — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved an original ANDA for pitavastatin calcium from Upsher-Smith Laboratories, making a generic pitavastatin product available.
-
FDA approval · 2017-02-02FDA Approved: PRAVASTATIN SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for pravastatin sodium tablets from Aurobindo Pharma Limited, providing a generic option for cholesterol manag…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]
Phase 1 clinical trial update evaluating pharmacokinetic interaction and safety of telmisartan/amlodipine with rosuvastatin in hypertension …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]
Phase 1 PK study of YH22189 fixed-dose combination compared with Telmisartan/Amlodipine and Rosuvastatin was terminated. The study targeted …
-
CLINICAL_TRIALS research · 2017-01-30Clinical Trial Update: Effects of Quinoa Consumption on Markers of Cardiovascular Risk and Gastrointestinal Health [NA]
A Newcastle University clinical trial is investigating whether quinoa consumption affects fasting LDL-cholesterol and other cardiovascular a…
-
FDA approval · 2017-01-25FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
The FDA page indicates a supplemental application for Repatha (evolocumab) submitted by Amgen USA Inc.; the submission status is AP.
-
FDA approval · 2017-01-23FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Pravastatin Sodium (generic) from Teva Pharmaceuticals USA, Inc. The approval confirms the c…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled [Phase 3]
Phase 3 trial assessing the efficacy and safety of KI1107 in patients with dyslipidemias whose triglycerides are not adequately controlled w…
-
FDA approval · 2017-01-19FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers [Phase 1]
Phase 1 pharmacokinetic study of CJ-30060 after a single dose in healthy male volunteers completed; the study examined absorption and dispos…
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia
This clinical trial update describes an observational study evaluating the effectiveness and safety of Olostar Tab in patients with essentia…